|
Volume
7 Number 8
August 2019
|
|
Home
>
Disciplines
>
Publications
>
Prostate
Cancer Research
>
Volume
7, Year 2019
>
Number 8, August
|
|
|
CONTENTS
|
▼
|
|
DIAGNOSIS
FOLLOW-UP,
QUALITY OF LIFE
PROGNOSIS
TREATMENT
|
|
|
DIAGNOSIS
|
▲
|
.
|
Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C,
Bach-Gansmo T, Nanni C, Savir-Baruch B, Elashoff D, Grogan T,
Dahlbom M, Slavik R, Gartmann J, Nguyen K, Lok V, Jadvar H, Kishan
AU, Rettig MB, Reiter RE, Fendler WP, Czernin J.
18F-fluciclovine
PET-CT and 68Ga-PSMA-11 PET-CT in
patients with early biochemical recurrence after prostatectomy: a
prospective, single-centre, single-arm, comparative imaging trial.
Lancet Oncol. 2019 Sep;20(9):1286-1294. doi:
10.1016/S1470-2045(19)30415-2. Epub 2019 Jul 30.
Source
.
Similar
articles
|
|
|
.
|
Couñago F, Díaz Gavela AA, Sancho G, Ortiz I, Marcos
FJ, Recio M, Fernández J, Cano R, Jiménez M,
Thuissard IJ, Sanz-Rosa D, Castro Nováis J, Pardo E, Molina
Y, Pérez García H, Del Cerro E.
Multiparametric
magnetic resonance imaging-guided salvage radiotherapy in prostate
cancer.
Rep Pract Oncol Radiother. 2019
Sep-Oct;24(5):472-480. doi: 10.1016/j.rpor.2019.07.008. Epub 2019
Aug 8.
Source
.
Similar
articles
|
|
|
.
|
Choyke P.
Editorial: assessment of 68Ga-PSMA-11
PET accuracy in localizing recurrent prostate cancer, a
prospective single arm clinical study: California shows the way!
Transl Androl Urol. 2019 Jul;8(Suppl 3):S296-S299. doi:
10.21037/tau.2019.06.11.
Source
.
Similar
articles
Referring
to: Fendler WP, et al, Assessment of 68Ga-PSMA-11 PET Accuracy in
Localizing Recurrent Prostate Cancer: A Prospective Single-Arm
Clinical Trial. JAMA Oncol. 2019 Jun 1;5(6):856-863. doi:
10.1001/jamaoncol.2019.0096.
Source
.
Similar
articles
|
|
|
.
|
Dell'Oglio P, Stabile A, Soligo M, Brembilla G, Esposito A,
Gandaglia G, Fossati N, Bravi CA, Dehò F, De Cobelli F,
Montorsi F, Karnes RJ, Briganti A.
There Is No Way to
Avoid Systematic Prostate Biopsies in Addition to Multiparametric
Magnetic Resonance Imaging Targeted Biopsies.
Eur Urol
Oncol. 2019 Mar 27. pii: S2588-9311(19)30033-1. doi:
10.1016/j.euo.2019.03.002. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY,
Nguyen HG, Reiter RE, Rettig MB, Okamoto S, Emmett L, Zacho HD,
Ilhan H, Wetter A, Rischpler C, Schoder H, Burger IA, Gartmann J,
Smith R, Small EJ, Slavik R, Carroll PR, Herrmann K, Czernin J,
Hope TA.
Assessment of 68Ga-PSMA-11 PET Accuracy in
Localizing Recurrent Prostate Cancer: A Prospective Single-Arm
Clinical Trial.
JAMA Oncol. 2019 Jun 1;5(6):856-863.
doi: 10.1001/jamaoncol.2019.0096.
Source
.
Similar
articles
|
|
|
.
|
Kranzbühler B, Müller J, Becker AS, Garcia Schüler
HI, Muehlematter UJ, Fankhauser CD, Kedzia S, Guckenberger M,
Kaufmann PA, Eberli D, Burger IA.
Detection rate and
localization of prostate cancer recurrence using 68Ga-PSMA-11
PET/MRI in patients with low PSA values ≤ 0.5 ng/ml.
J
Nucl Med. 2019 Aug 2. pii: jnumed.118.225276. doi:
10.2967/jnumed.118.225276. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Miah S, Hosking-Jervis F, Connor MJ, Eldred-Evans D, Shah TT, Arya
M, Barber N, Bhardwa J, Bott S, Burke D, Doherty A, Foster C,
Freeman A, Hindley R, Jameson C, Karim O, Laniado M, Montgomery B,
Nigam R, Punwani S, Sinclair A, Winkler M, Allen C, Ahmed HU.
A
Multicentre Analysis of the Detection of Clinically Significant
Prostate Cancer Following Transperineal Image-fusion Targeted and
Nontargeted Systematic Prostate Biopsy in Men at Risk.
Eur
Urol Oncol. 2019 Mar 29. pii: S2588-9311(19)30038-0. doi:
10.1016/j.euo.2019.03.005. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Rousseau C, Le Thiec M, Ferrer L, Rusu D, Rauscher A, Maucherat B,
Frindel M, Baumgartner P, Fleury V, Denis A, Morel A, Varmenot N,
Debeaupuis E, Campion L, Kraeber-Bodéré F.
Preliminary results of a 68 Ga-PSMA
PET/CT prospective study in prostate cancer patients with occult
recurrence: Diagnostic performance and impact on therapeutic
decision-making.
Prostate. 2019 Sep;79(13):1514-1522.
doi: 10.1002/pros.23869. Epub 2019 Aug 17.
Source
.
Similar
articles
|
|
|
.
|
van Leenders GJLH, Kweldam CF, Hollemans E, Kümmerlin IP,
Nieboer D, Verhoef EI, Remmers S, Incrocci L, Bangma CH, van der
Kwast TH, Roobol MJ.
Improved Prostate Cancer Biopsy
Grading by Incorporation of Invasive Cribriform and Intraductal
Carcinoma in the 2014 Grade Groups.
Eur Urol. 2019 Aug
19. pii: S0302-2838(19)30612-8. doi: 10.1016/j.eururo.2019.07.051.
[Epub ahead of print]
Source
.
Similar
articles
|
|
|
FOLLOW-UP,
QUALITY OF LIFE
|
▲
|
.
|
Della Camera PA, Tellini R, Cito G, Rastrelli G, Maggi M, Chini T,
Nunzio C, Altieri VM, Serni S, Gacci M, Natali A.
Efficacy
and safety of avanafil 200 mg versus sildenafil 100 mg in the
treatment of erectile dysfunction after robot-assisted unilateral
nerve-sparing prostatectomy: A prospective multicentre study.
Urologia. 2019 Aug 23:391560319867809. doi:
10.1177/0391560319867809. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
PROGNOSIS
|
▲
|
.
|
Cook GJR, Kulkarni M, Warbey VS.
PSMA PET/CT imaging for
primary staging of intermediate and high-risk prostate cancer.
BJU Int. 2019 Sep;124(3):357-358. doi: 10.1111/bju.14856.
Source
.
Similar
articles
Editorial
referring to: Yaxley JW, et al, Risk of metastatic disease on 68
gallium-prostate-specific
membrane antigen positron emission tomography/computed tomography
scan for primary staging of 1253 men at the diagnosis of prostate
cancer.
BJU Int. 2019 Sep;124(3):401-407. doi:
10.1111/bju.14828. Epub 2019 Jul 2.
Source
.
Similar
articles
|
|
|
.
|
Martini A, Gandaglia G, Fossati N, Scuderi S, Bravi CA, Mazzone E,
Stabile A, Scarcella S, Robesti D, Barletta F, Cucchiara V, Mirone
V, Montorsi F, Briganti A.
Defining Clinically Meaningful
Positive Surgical Margins in Patients Undergoing Radical
Prostatectomy for Localised Prostate Cancer.
Eur Urol
Oncol. 2019 Apr 4. pii: S2588-9311(19)30039-2. doi:
10.1016/j.euo.2019.03.006. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Miyake M, Tanaka N, Asakawa I, Owari T, Hori S, Morizawa Y, Nakai
Y, Inoue T, Anai S, Torimoto K, Hasegawa M, Fujii T, Konishi N,
Fujimoto K.
The impact of the definition of biochemical
recurrence following salvage radiotherapy on outcomes and
prognostication in patients with recurrent prostate cancer after
radical prostatectomy: a comparative study of three definitions.
Prostate Int. 2019 Jun;7(2):47-53. doi:
10.1016/j.prnil.2018.04.005. Epub 2018 May 5.
Source
.
Similar
articles
|
|
|
.
|
Preisser F, Bandini M, Nazzani S, Mazzone E, Marchioni M, Tian Z,
Chun FKH, Saad F, Briganti A, Haese A, Montorsi F, Huland H,
Graefen M, Tilki D, Karakiewicz PI.
Development and
Validation of a Lookup Table for the Prediction of Metastatic
Prostate Cancer According to Prostatic-specific Antigen Value,
Clinical Tumor Stage, and Gleason Grade Groups.
Eur Urol
Oncol. 2019 Mar 28. pii: S2588-9311(19)30035-5. doi:
10.1016/j.euo.2019.03.003. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Radtke JP, Giganti F, Wiesenfarth M, Stabile A, Marenco J, Orczyk
C, Kasivisvanathan V, Nyarangi-Dix JN, Schütz V,
Dieffenbacher S, Görtz M, Stenzinger A, Roth W, Freeman A,
Punwani S, Bonekamp D, Schlemmer HP, Hohenfellner M, Emberton M,
Moore CM.
Prediction of significant prostate cancer in
biopsy-naïve men: Validation of a novel risk model combining
MRI and clinical parameters and comparison to an ERSPC risk
calculator and PI-RADS.
PLoS One. 2019 Aug
26;14(8):e0221350. doi: 10.1371/journal.pone.0221350. eCollection
2019.
Source
.
Similar
articles
|
|
|
.
|
Sato S, Kimura T, Yorozu T, Onuma H, Iwatani K, Egawa S, Ikegami
M, Takahashi H.
Cases Having a Gleason Score 3+4=7 With
<5% of Gleason Pattern 4 in Prostate Needle Biopsy Show Similar
Failure-free Survival and Adverse Pathology Prevalence to Gleason
Score 6 Cases in a Radical Prostatectomy Cohort.
Am J
Surg Pathol. 2019 Aug 20. doi: 10.1097/PAS.0000000000001345. [Epub
ahead of print]
Source
|
Abstract
|
Similar
articles
|
|
|
.
|
Vau N, Henriques V, Cheng L, Blanca A, Fonseca J, Montironi R,
Cimadamore A, Lopez-Beltran A.
Predicting biochemical
recurrence after radical prostatectomy: the role of prognostic
grade group and index tumor nodule.
Hum Pathol. 2019 Aug
20. pii: S0046-8177(19)30151-0. doi:
10.1016/j.humpath.2019.08.012. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Yaxley JW, Raveenthiran S, Nouhaud FX, Samaratunga H, Yaxley WJ,
Coughlin G, Yaxley AJ, Gianduzzo T, Kua B, McEwan L, Wong D.
Risk
of metastatic disease on 68
gallium-prostate-specific membrane antigen positron emission
tomography/computed tomography scan for primary staging of 1253
men at the diagnosis of prostate cancer.
BJU Int. 2019
Sep;124(3):401-407. doi: 10.1111/bju.14828. Epub 2019 Jul 2.
Source
.
Similar
articles
|
|
|
.
|
Zhu X, Gou X, Zhou M.
Nomograms Predict Survival
Advantages of Gleason Score 3+4 Over 4+3 for Prostate Cancer: A
SEER-Based Study.
Front Oncol. 2019 Jul 16;9:646. doi:
10.3389/fonc.2019.00646. eCollection 2019.
Source
.
Similar
articles
|
|
|
TREATMENT
|
▲
|
.
|
Deek MP, Yu C, Phillips R, Song DY, Deville C, Greco S, DeWeese
TL, Antonarakis ES, Markowski M, Paller C, Denmeade S, Carducci M,
Walsh PC, Pienta KJ, Eisenberger M, Tran PT.
Radiotherapy
In The Definitive Management Of Oligometastatic Prostate Cancer:
The Johns Hopkins Experience.
Int J Radiat Oncol Biol
Phys. 2019 Aug 13. pii: S0360-3016(19)33641-7. doi:
10.1016/j.ijrobp.2019.08.008. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Hackman G, Taari K, Tammela TL, Matikainen M, Kouri M, Joensuu T,
Luukkaala T, Salonen A, Isotalo T, Pétas A, Hendolin N,
Boström PJ, Aaltomaa S, Lehtoranta K, Hellström P,
Riikonen J, Korpela M, Minn H, Kellokumpu-Lehtinen PL, Pukkala E,
Hemminki A; FinnProstate Group.
Randomised Trial of
Adjuvant Radiotherapy Following Radical Prostatectomy Versus
Radical Prostatectomy Alone in Prostate Cancer Patients with
Positive Margins or Extracapsular Extension.
Eur Urol.
2019 Jul 17. pii: S0302-2838(19)30525-1. doi:
10.1016/j.eururo.2019.07.001. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Poulsen MH, Jakobsen JS, Mortensen MA, Høilund-Carlsen PF,
Lund L.
Does therapy of the primary tumor matter in
oligometastatic prostate cancer? A prospective 10-year follow-up
study.
Res Rep Urol. 2019 Jul 30;11:215-221. doi:
10.2147/RRU.S190140. eCollection 2019.
Source
.
Similar
articles
|
|
|
.
|
Zilli T, Franzese C, Bottero M, Giaj-Levra N, Förster R,
Zwahlen D, Koutsouvelis N, Bertaut A, Blanc J, Roberto D'agostino
G, Alongi F, Guckenberger M, Scorsetti M, Miralbell R.
Single
fraction urethra-sparing prostate cancer SBRT: Phase I results of
the ONE SHOT trial.
Radiother Oncol. 2019 Aug 17. pii:
S0167-8140(19)33011-7. doi: 10.1016/j.radonc.2019.07.018. [Epub
ahead of print]
Source
.
Similar
articles
|
|
|
bottom
|
▲
|
|
|